Market revenue in 2023 | USD 213.1 million |
Market revenue in 2030 | USD 462.4 million |
Growth rate | 11.7% (CAGR from 2023 to 2030) |
Largest segment | Outsourcing |
Fastest growing segment | Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In-House, Outsourcing |
Key market players worldwide | Steris PLC, Sotera Health Co Ordinary Shares, Sartorius AG, Solvias, SGS AG, Labcorp Holdings Inc, Pace Analytical Services, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Rapid Micro Biosystems Inc Class A, Almac Group, Pacific BioLabs, Inc., Boston Analytical, Labor LS |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical sterility testing market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 58.94% in 2023. Horizon Databook has segmented the Canada pharmaceutical sterility testing market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
The presence of manufacturing units of large market players, such as Valeant, Johnson & Johnson, Sanofi Pasteur, Teva, Schering-Plough, Pfizer, Sandoz, GlaxoSmithKline, Inc., and Apotex, is expected to propel market growth.
These multinational enterprises in Canada are also adopting advanced manufacturing techniques and are diversifying their product portfolios into areas such as consumer healthcare, OTC products, and medical devices.
This diversification is anticipated to increase the demand for sterility testing as each batch is expected to pass the test before release. Moreover, indirect investments and outsourcing of sterility testing services by market players are anticipated to increase the demand for Canadian contract service providers.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada pharmaceutical sterility testing market , including forecasts for subscribers. This country databook contains high-level insights into Canada pharmaceutical sterility testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account